Gene · 2273
Papers1,852
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 1,852
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Zinc Supplementation Induced Transcriptional Changes in Primary Human Retinal Pigment Epithelium: A Single-Cell RNA Sequencing Study to Understand Age-Related Macular Degeneration. | Cells | 2023 | 36899910 | PubTator, text mining | PubMed |
| Diagnostic and Prognostic Comparison of Immune-Complex-Mediated Membranoproliferative Glomerulonephritis and C3 Glomerulopathy. | Cells | 2023 | 36899849 | PubTator, text mining | PubMed |
| Mechanisms of pathogenicity in the hypertrophic cardiomyopathy-associated TPM1 variant S215L. | PNAS Nexus | 2023 | 36896133 | PubTator, text mining | PubMed |
| cMyBP-C ablation in human engineered cardiac tissue causes progressive Ca2+-handling abnormalities. | J Gen Physiol | 2023 | 36893011 | PubTator, text mining | PubMed |
| Preferential production and secretion of the complement regulator factor H-like protein 1 (FHL-1) by human myeloid cells. | Immunobiology | 2023 | 36881973 | PubTator, text mining | PubMed |
| Integrated bioinformatics analyses identifying key transcriptomes correlated with prognosis and immune infiltrations in lung squamous cell carcinoma. | Saudi J Biol Sci | 2023 | 36879671 | PubTator, text mining | PubMed |
| Corneal epithelial development and homeostasis. | Differentiation | 2023 | 36870804 | PubTator, text mining | PubMed |
| Identification of novel FHL1 mutations associated with X-linked scapuloperoneal myopathy in unrelated Chinese patients. | J Hum Genet | 2023 | 36864287 | PubTator, text mining | PubMed |
| Immunomodulatory potential of mesenchymal stem cell-derived extracellular vesicles: Targeting immune cells. | Front Immunol | 2023 | 36860847 | PubTator, text mining | PubMed |
| Space Omics and Tissue Response in Astronaut Skeletal Muscle after Short and Long Duration Missions. | Int J Mol Sci | 2023 | 36835504 | PubTator, text mining | PubMed |
| The Dual Function of RhoGDI2 in Immunity and Cancer. | Int J Mol Sci | 2023 | 36835422 | PubTator, text mining | PubMed |
| Tumor Androgen Receptor Protein Level Is Positively Associated with a Better Overall Survival in Melanoma Patients. | Genes (Basel) | 2023 | 36833272 | PubTator, text mining | PubMed |
| The human inactive X chromosome modulates expression of the active X chromosome. | Cell Genom | 2023 | 36819663 | PubTator, text mining | PubMed |
| An integrated study of hormone-related sarcopenia for modeling and comparative transcriptome in rats. | Front Endocrinol (Lausanne) | 2023 | 36817606 | PubTator, text mining | PubMed |
| Effects of Exosomes on Tumor Bioregulation and Diagnosis. | ACS Omega | 2023 | 36816660 | PubTator, text mining | PubMed |
| Anti-RuvBL1/2 Autoantibodies Detection in a Patient with Overlap Systemic Sclerosis and Polymyositis. | Antibodies (Basel) | 2023 | 36810518 | PubTator, text mining | PubMed |
| A proteomics approach to identify COPD-related changes in lung fibroblasts. | Am J Physiol Lung Cell Mol Physiol | 2023 | 36808722 | PubTator, text mining | PubMed |
Genome-wide epigenetic and mRNA-expression profiling followed by CRISPR/Cas9-mediated gene-disruptions corroborate the MIR141/MIR200C-ZEB1/ZEB2-FGFR1 axis in acquired EMT-associated EGFR TKI-resistance in NSCLC cells. | Transl Lung Cancer Res | 2023 | 36762066 | PubTator, text mining | PubMed |
| Expression and Predictive Significance of FHL1 and SLIT3 in Surgically Resected Lung Adenocarcinoma. | Comb Chem High Throughput Screen | 2023 | 36752296 | PubTator, text mining | PubMed |
| Comprehensive Molecular Analyses of Notch Pathway-Related Genes to Predict Prognosis and Immunotherapy Response in Patients with Gastric Cancer. | J Oncol | 2023 | 36733672 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2273/papers?page=12